Mirae Asset Global Investments
MDGL icon

Mirae Asset Global Investments’s Madrigal Pharmaceuticals MDGL Stock Holding History

Mirae Asset Global Investments’s Portfolio MDGL Stock Details MDGL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$17.9M Sell
33,420
-7,506
-18% -$3.84M 0.03% 328
2026
Q1 		$21.4M Sell
40,926
-9,705
-19% -$4.64M 0.01% 256
2025
Q4 		$29.5M Buy
50,631
+53
+0.1% +$27.1K 0.08% 199
2025
Q3 		$23.2M Sell
50,578
-19,981
-28% -$7.45M 0.07% 218
2025
Q2 		$21.4M Buy
70,559
+218
+0.3% +$65K 0.07% 214
2025
Q1 		$23.3M Buy
70,341
+162
+0.2% +$53.2K 0.1% 166
2024
Q4 		$21.9M Sell
70,179
-6,643
-9% -$1.87M 0.09% 175
2024
Q3 		$16.3M Sell
76,822
-5,915
-7% -$1.51M 0.07% 191
2024
Q2 		$23.6M Sell
82,737
-9,516
-10% -$2.27M 0.12% 140
2024
Q1 		$24.5M Buy
92,253
+30,745
+50% +$7.24M 0.05% 353
2023
Q4 		$14.4M Sell
61,508
-767
-1% -$134K 0.03% 521
2023
Q3 		$9.24M Buy
62,275
+15,304
+33% +$2.88M 0.02% 638
2023
Q2 		$10.5M Buy
+46,971
New +$12.7M 0.02% 627
2018
Q3 		– Sell
-3,000
Closed -$839K – 1328
2018
Q2 		$839K Buy
+3,000
New +$527K 0.01% 535

Other funds holding MDGL

Pictet Asset Management
Pictet Asset Management Carouge, Switzerland $105B AUM 38.07% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $79.3B AUM 43.63% 1-Year Est. Return
EAM
EULAV Asset Management Sarasota, Florida $3.13B AUM 23.04% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
SAM
Shikiar Asset Management New York $396M AUM 41.06% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.94% 1-Year Est. Return
WC
Waterloo Capital Austin, Texas $1.78B AUM 27.25% 1-Year Est. Return
TD Asset Management
TD Asset Management Toronto, Ontario, Canada $115B AUM 41.58% 1-Year Est. Return

Mirae Asset Global Investments's MDGL Position: Q2 2026 in Review

Mirae Asset Global Investments reduced its Madrigal Pharmaceuticals (MDGL) stake by 18% in Q2 2026, selling an estimated $3.84M and leaving 33,420 shares worth $17.9M. The position accounts for 0.03% of the portfolio, ranked #328.

Mirae Asset Global Investments first reported a position in MDGL in Q2 2018 and has held it in 14 quarters since. The position peaked at $29.5M in Q4 2025. 109 funds tracked by Wall St. Rank hold MDGL as of Q2 2026.

  • Mirae Asset Global Investments held 33,420 shares of Madrigal Pharmaceuticals worth $17.9M as of Q2 2026.
  • Mirae Asset Global Investments sold 7,506 Madrigal Pharmaceuticals shares in Q2 2026, an estimated $3.84M.
  • Madrigal Pharmaceuticals made up 0.03% of Mirae Asset Global Investments's portfolio in Q2 2026, its #328 holding.
  • Mirae Asset Global Investments first reported a position in Madrigal Pharmaceuticals in Q2 2018 and has held it in 14 quarters since.
  • Mirae Asset Global Investments's Madrigal Pharmaceuticals position peaked at $29.5M in Q4 2025.
  • 109 funds tracked by Wall St. Rank held Madrigal Pharmaceuticals as of Q2 2026.

Based on Mirae Asset Global Investments's 13F filing for Q2 2026, filed 22 Jul 2026.